Systemic evaluation of cellular reprogramming processes exploiting a novel R-tool: eegc
Motivation: Cells derived by cellular engineering, i.e. differentiation of induced pluripotent stem cells and direct lineage reprogramming, carry a tremendous potential for medical applications and in particular for regenerative therapies. These approaches consist in the definition of lineage-specific experimental protocols that, by manipulation of a limited number of biological cues-niche mimicking factors, (in) activation of transcription factors, to name a few-enforce the final expression of cell-specific (marker) molecules.






